Literature DB >> 26720440

Human Corneal MicroRNA Expression Profile in Fungal Keratitis.

Hemadevi Boomiraj1, Vidyarani Mohankumar1, Prajna Lalitha1, Bharanidharan Devarajan2.   

Abstract

PURPOSE: MicroRNAs (miRNAs) are small, stable, noncoding RNA molecules with regulatory function and marked tissue specificity that posttranscriptionally regulate gene expression. However, their role in fungal keratitis remains unknown. The purpose of this study was to identify the miRNA profile and its regulatory role in fungal keratitis.
METHODS: Normal donor (n = 3) and fungal keratitis (n = 5) corneas were pooled separately, and small RNA deep sequencing was performed using a sequencing platform. A bioinformatics approach was applied to identify differentially-expressed miRNAs and their targets, and select miRNAs were validated by real-time quantitative PCR (qPCR). The regulatory functions of miRNAs were predicted by combining miRNA target genes and pathway analysis. The mRNA expression levels of select target genes were further analyzed by qPCR.
RESULTS: By deep sequencing, 75 miRNAs were identified as differentially expressed with fold change greater than 2 and probability score greater than 0.9 in fungal keratitis corneas. The highly dysregulated miRNAs (miR-511-5p, miR-142-3p, miR-155-5p, and miR-451a) may regulate wound healing as they were predicted to specifically target wound inflammatory genes. Moreover, the increased expression of miR-451a in keratitis correlated with reduced expression of its target, macrophage migration inhibitory factor, suggesting possible regulatory functions.
CONCLUSIONS: This is, to our knowledge, the first report on comprehensive human corneal miRNA expression profile in fungal keratitis. Several miRNAs with high expression in fungal keratitis point toward their potential role in regulation of pathogenesis. Further insights in understanding their role in corneal wound inflammation may help design new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26720440     DOI: 10.1167/iovs.15-17619

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

2.  MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1.

Authors:  Xiuqin Wang; Yanqing Guo; Chunyan Wang; Hong Yu; Xiuxiang Yu; Hongbo Yu
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

3.  Fungal keratitis: study of increasing trend and common determinants.

Authors:  Yogesh Acharya; Bhawana Acharya; Priyanka Karki
Journal:  Nepal J Epidemiol       Date:  2017-06-30

Review 4.  MicroRNAs in Ocular Infection.

Authors:  Shunbin Xu; Linda D Hazlett
Journal:  Microorganisms       Date:  2019-09-17

5.  Inhibition of miR-665-3p Enhances Autophagy and Alleviates Inflammation in Fusarium solani-Induced Keratitis.

Authors:  Qunqin Guo; Yi Lin; Jianzhang Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-01-04       Impact factor: 4.799

Review 6.  Infectious Keratitis: An Update on Role of Epigenetics.

Authors:  Sudhir Verma; Aastha Singh; Akhil Varshney; R Arun Chandru; Manisha Acharya; Jyoti Rajput; Virender Singh Sangwan; Amit K Tiwari; Tuhin Bhowmick; Anil Tiwari
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

7.  MiR-223-3p Regulates Autophagy and Inflammation by Targeting ATG16L1 in Fusarium solani-Induced Keratitis.

Authors:  Hanfeng Tang; Yi Lin; Liwei Huang; Jianzhang Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

8.  Metformin inhibits high glucose-induced smooth muscle cell proliferation and migration.

Authors:  Dong-Ming Zhou; Feng Ran; Hai-Zhen Ni; Li-Li Sun; Lun Xiao; Xiao-Qiang Li; Wen-Dong Li
Journal:  Aging (Albany NY)       Date:  2020-03-24       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.